Aim of the study. Show the possibilities of diagnosing non - tuberculous mycobacteriosis of the lungs (NTML) in the practice of the pulmonologist. Materials and methods. A survey of 90 patients with a confirmed diagnosis of non - tuberculous mycobacteriosis of the lungs (NTML) was presented. The diagnosis of pulmonary mycobacteriosis was established in accordance with the criteria proposed in 2007 by the American Thoracic Society and the American Society of Infectious Diseases (ATS/IDRS). Among the patients, 55 (61.1%) women prevailed, the average age was 51.2±15.3 years. Patients were evaluated complaints, the presence of concomitant diseases of the lungs, was carried out computed tomography of the chest high - resolution (HRCT), a culture study of sputum, in the absence of sputum or a single determination of the NTM culture in it, a study was conducted on materials of bronchoalveolar washout (ALS/BAL), or lung biopsies. Statistical processing of the research results was performed using descriptive statistics using Microsoft® Excel for Windows xp® on a personal computer. Results and conclusion. As a result of the study, it was revealed that before the diagnosis of NTML was established, 66.7% of patients were long observed for chronic lung diseases (chronic obstructive pulmonary disease, chronic bronchitis), and in 55.6% of cases (50 people) were registered with a phthisiologist about pulmonary tuberculosis. According to the CT scan of OGK, dissemination was determined in 66.7% of cases, in 48.9% - bronchiectasis, single or multiple destruction cavities - 46.7% of cases. In 72.2% of cases, non - tuberculous mycobacteria (NTM) were found in sputum, in 33.3% - in ALS and in 22.2% of NTMs were found in the surgical material. In 14.4% of cases, only surgery allowed to establish the diagnosis of mycobacteriosis.
Aim: to study radiological semiotics of peripheral pulmonary lesions (PPLs) detected by CT of the chest, and establish radiological patterns, which significantly increase effectiveness of navigation bronchobiopsies. Materials and methods. A cohort retrospective study included 278 patients with PPLs with verified diagnoses established by invasive diagnostic procedures (navigation bronchoscopy with a complex of biopsies and/or diagnostic thoracic surgery). The study included 162 (58.3%) women aged 13 to 80 yrs. (average age – 46.21 ± 5.23) and 116 (41.7%) men aged 14 to 85 yrs. (average age – 46.05 ± 3.49). The patients were divided into 4 nosological groups: pulmonary TB patients – 158 (56.8%), neoplastic patients – 79 (28.4%), nontuberculous pulmonary mycobacteriosis (NTPM) patients – 21 (7.6%), and protracted course community-acquired pneumonia (CAP) patients (presentations of PPLs) – 20 (7.2%). Results. According to chest CT data, PPLs had three major radiological sings, defined as “infiltrate”, “rounded shadow”, and “focus”. Rounded shadows prevailed in NTPM patients and neoplastic patients. Statistically significant differences between the groups were as follows: the medium maximum size and contour of PPLs (focus / rounded shadow / infiltrate), the presence of bronchiectasis and the type of foci (lobular/sublobular/acinar) in the lung parenchyma surrounding PPLs, the presence of calcification, cavitation, or air bronchograms inside PPLs. The total effectiveness of bronchoscopic verification of PPLs in patients with “CT bronchus sign” was 79.4%, which significantly exceeded diagnosis verification in patients without it (17.9%) (р < 0.001). The effectiveness of diagnosis verification by bronchobiopsy in patients with PPLs less than 20 mm (CT data) achieved 50% irrespective of etiology. The most effective bronchoscopic verification of diagnoses was observed in TB and NTPM patients with PPLs ≥ 20 mm – 83.3% and 100.0% respectively, and in neoplastic patients with PPLs ≥ 30 mm it reached 93.0%. The lobar localization of the process did not affect the diagnostic effectiveness of bronchobiopsies. Conclusion. The highest effectiveness of bronchobiopsies was observed in patients with the CT bronchus sign and with PPLs ≥ 20 mm or ≥ 30 mm (CT data). The volume of diagnostic biopsies obtained by navigation bronchoscopy or surgical resection should be determined by radiological morphology of PPLs with estimation of malignancy or benign signs revealed by CT of the chest.
The pulmonary disease caused by nontuberculous mycobacteria (NTM) is a chronic respiratory infection resulting in declining lung function, worsening life quality, and increasing mortality rates. Most patients with pulmonary nontuberculous mycobacteriosis (PNTM) have concomitant chronic diseases (bronchiectatic disease, COPD, diabetes mellitus, etc.) PNTM is a refractory disease as mycobacteria are located intracellularly in alveolar macrophages. Mycobacteria can develop a biofilm, which impedes antibiotic penetration and protects them. Treatment for PNTM is long-term with low effectiveness due to innate or acquired mycobacterial resistance. The article outlines the modern concepts of drug resistance development in NTM, refractoriness of the disease, and the current mechanisms to overcome it.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.